1LPH
LYS(B28)PRO(B29)-HUMAN INSULIN
1LPH の概要
| エントリーDOI | 10.2210/pdb1lph/pdb |
| 分子名称 | INSULIN, ZINC ION, PHENOL, ... (6 entities in total) |
| 機能のキーワード | insulin analogue, hormone, glucose metabolism |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| 細胞内の位置 | Secreted: P01308 P01308 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 11895.68 |
| 構造登録者 | Ciszak, E.,Beals, J.M.,Frank, B.H.,Baker, J.C.,Carter, N.D.,Smith, G.D. (登録日: 1995-04-19, 公開日: 1996-06-20, 最終更新日: 2024-11-13) |
| 主引用文献 | Ciszak, E.,Beals, J.M.,Frank, B.H.,Baker, J.C.,Carter, N.D.,Smith, G.D. Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin. Structure, 3:615-622, 1995 Cited by PubMed Abstract: LysB28ProB29-human insulin (Humalog), a fully potent insulin analog in which the prolyl, lysyl sequence at the C-terminal end of the B-chain is inverted, exhibits a decreased association of monomers to dimers leading to rapid in vivo absorption. This provides important benefits for the insulin-requiring diabetic. In spite of its monomeric nature, LysB28ProB29-human insulin can exist as a discrete hexameric structure in the presence of both zinc and phenol. Studies of the crystal structure of LysB28ProB29-human insulin in a hexameric complex were initiated to gain a molecular understanding of the effect of the sequence inversion on the analog's self-association properties and, consequently, its in vivo efficacy. PubMed: 8590022DOI: 10.1016/S0969-2126(01)00195-2 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






